Nilutamide vs Rituximab

## Nilutamide vs Rituximab: Overview

This comparison examines the pharmacological differences between **Nilutamide** and **Rituximab**.

## Mechanism of Action

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Nilutamide — N/A; Rituximab — 22 days.

## Chemical Properties

**Type**: Nilutamide — Small molecule; Rituximab — Antibody.